Your browser doesn't support javascript.
loading
Evaluation of Patients Treated with Lipo-prostaglandin E 1 for Chronic Severe Type B Hepatitis by MELD Prognosis Analysis / 中国药房
China Pharmacy ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-527831
ABSTRACT

OBJECTIVE:

To investigate the therapeutic effect of Lipo-prostaglandin E 1 (Lipo PGE 1 )on chronic severe type B hepatitis by MELD(Model for end-stage live disease)prognosis analysis.

METHODS:

Of a total of115cases with chronic severe type B hepatitis,57were randomly assigned to receive a common combined therapy and58to receive a common combined therapy plus Lipo PGE 1 for4weeks,the MELD score and prognosis of diseases of the2groups were assessed.RE-SULTSThe MELD score in the treatment group(20.12?8.97)was lower than that of the control group(24.76?10.41)after4weeks’treatment(P

Full text: Available Index: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article